Jubilant Pharmova LtdPharmaceuticalsINE700A01033Consolidated₹1065.40+53.30 (+5.27%)Jun-26
Valuation
Market Cap₹16.97K Cr
TTM PE47.93x
Forward PE54.58x
PEG-4.13
Book Value₹445.30
P/B2.39x
TTM EPS₹22.23
Fwd EPS₹19.52
TTM Revenue₹8.61K Cr
TTM PAT₹351.40 Cr
TTM EBITDA₹1.22K Cr
TTM EBIT₹748.60 Cr
Last Qtr PAT₹56.40 Cr
Last Qtr EBITDA₹248.00 Cr
Last Qtr EBIT₹120.70 Cr
Profitability
ROE4.95%
ROCE7.17%
TTM NPM4.08%
TTM EBITDA %14.15%
Curr OPM2.51%
Last OPM5.16%
Curr NPM—
Last NPM—
Curr EPS₹3.57
Last EPS₹7.55
Balance sheet
Equity₹15.80 Cr
Reserve₹7.08K Cr
Total Debt₹3,547.70 Cr
D/E0.50x
Interest %96.10%
Curr Interest₹54.20 Cr
Price / range
Close₹1065.40
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+5.27%
1W+3.92%
1M+23.03%
3M+9.45%
6M+24.36%
1Y-4.44%
2Y-11.14%
3Y+141.18%
5Y+73.42%
Diwali+0.90%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits